Salarius Pharmaceuticals ... (SLRX)
2.55
-0.09 (-3.41%)
At close: Jan 15, 2025, 3:59 PM
2.68
5.10%
After-hours Jan 15, 2025, 04:39 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| Net Income | -12.54M | -31.61M | -12.77M | -7.35M | -6.94M | -21.92M | -34.43M | -39.49M | -29.14M | n/a |
| Depreciation & Amortization | 10.05K | 6.68K | 19.18K | 18.06K | 127.41K | 228.16K | 324.55K | 277.23K | 49.88K | n/a |
| Stock-Based Compensation | 524.84K | 796.80K | 559.04K | 319.39K | 751.62K | 1.94M | 4.22M | 6.57M | 6.60M | n/a |
| Other Working Capital | -193.35K | 1.06M | 2.35M | -3.04M | -3.69M | -2.45M | 1.39M | 728.34K | 1.11M | n/a |
| Other Non-Cash Items | 130.00K | 10.84M | -44.69K | -258.55K | -1.31M | 20.31K | 1.78K | 3.43K | 4.12K | n/a |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 11.54K | -68.14K | 16.16K | 9.52K | n/a |
| Change in Working Capital | -968.33K | 2.37M | 2.03M | -3.04M | -4.21M | -3.88M | 2.23M | 571.46K | 1.73M | n/a |
| Operating Cash Flow | -12.85M | -17.60M | -10.20M | -10.31M | -11.58M | -23.60M | -27.72M | -32.05M | -20.75M | n/a |
| Capital Expenditures | -3 | -1.50M | n/a | -2.60K | n/a | n/a | -113.50K | -559.38K | -265.62K | n/a |
| Acquisitions | n/a | n/a | n/a | n/a | 5.61M | n/a | 5.34K | 5.25K | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -2.00M | -32.99M | -38.68M | -39.40M | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 16.12M | 57.59M | 27.00M | 12.40M | n/a |
| Other Investing Acitivies | n/a | -1.50M | n/a | n/a | 204.27K | 4.80K | 5.34K | 5.25K | n/a | n/a |
| Investing Cash Flow | n/a | -1.50M | n/a | -2.60K | 5.61M | 14.12M | 24.49M | -12.24M | -27.27M | n/a |
| Debt Repayment | -280.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | -133.59K | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | n/a | 28.30M | 17.69M | -417.88K | n/a | n/a | n/a | 400.00K | n/a |
| Financial Cash Flow | 6.64M | 1.99M | 28.30M | 17.69M | 3.58M | 118.01K | 2.63K | 22.10K | 80.84M | n/a |
| Net Cash Flow | -6.21M | -17.11M | 18.10M | 7.38M | -2.39M | -9.36M | -3.23M | -44.27M | 32.83M | n/a |
| Free Cash Flow | -12.85M | -19.10M | -10.20M | -10.31M | -11.58M | -23.60M | -27.84M | -32.61M | -21.01M | n/a |